Hot on the heels of the Elan and Roche deal comes one between Dow Pharma and Bristol-Myers Squibb (which curiously was released on both the 20th and 21st April). What’s the connection? Solubilization.
Related Posts
Timberland
14 February 2004 / Nanotechnology
NanoBuildings
15 February 2004 / Nanotechnology